NIH to divert portion of its budget to fund DoD medical countermeasure research
The National Institutes of Health has signed an agreement to transfer part of its budget to the Department of Defense for medical countermeasure projects.
Late last week, details emerged of a deal in which the National Institutes of Health will channel a portion of its funding to the Department of Defense. Under the agreement, NIH money earmarked for the National Institute of Allergy and Infectious Diseases will be used to finance DoD staff and projects aimed at advanced development of medical countermeasures for pandemic influenza, CBRN threats and emerging infectious diseases.
The contract, signed roughly a month earlier, spans a decade and draws from the $6.6 billion NIAID budget allocated by Congress for 2026. While the precise percentage is undisclosed, reports indicate the DoD was initially seeking up to a third of its total budget but agreed to about 10 percent. This arrangement comes as the defense budget, near $1 trillion, faces strain from ongoing conflicts, and the NIH struggles to award all the grants funded by Congress.
Why it matters
It shifts federal research money toward defense-run health projects, affecting how pandemic and bio-threat research is funded.
In this story
